| __timestamp | Eli Lilly and Company | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 14683100000 | 27632226 |
| Thursday, January 1, 2015 | 14921500000 | 97707000 |
| Friday, January 1, 2016 | 15567200000 | 129037000 |
| Sunday, January 1, 2017 | 16801100000 | 151332000 |
| Monday, January 1, 2018 | 16811600000 | 158719000 |
| Tuesday, January 1, 2019 | 17598300000 | 170104000 |
| Wednesday, January 1, 2020 | 19056500000 | 192195000 |
| Friday, January 1, 2021 | 21005600000 | 220706000 |
| Saturday, January 1, 2022 | 21911600000 | 204426000 |
| Sunday, January 1, 2023 | 27041900000 | 133788000 |
| Monday, January 1, 2024 | 36624400001 |
Unleashing insights
In the ever-evolving pharmaceutical industry, the financial health of companies is a key indicator of their market position and potential for innovation. Over the past decade, Eli Lilly and Company has demonstrated a robust growth trajectory, with its gross profit increasing by approximately 84% from 2014 to 2023. This growth reflects its strategic investments and successful product launches. In contrast, Travere Therapeutics, Inc., a smaller player in the industry, has shown a more modest increase in gross profit, peaking in 2021 before experiencing a decline in 2023. This divergence highlights the challenges faced by smaller biotech firms in scaling operations and achieving profitability. As the industry continues to evolve, these trends underscore the importance of strategic planning and innovation in maintaining competitive advantage.
Gross Profit Trends Compared: Eli Lilly and Company vs Novo Nordisk A/S
Who Generates Higher Gross Profit? Eli Lilly and Company or Incyte Corporation
Gross Profit Trends Compared: Eli Lilly and Company vs Catalent, Inc.
Gross Profit Trends Compared: Eli Lilly and Company vs Pharming Group N.V.
Gross Profit Analysis: Comparing Eli Lilly and Company and Grifols, S.A.
Gross Profit Analysis: Comparing Eli Lilly and Company and Amneal Pharmaceuticals, Inc.
Gross Profit Comparison: Eli Lilly and Company and Perrigo Company plc Trends
Eli Lilly and Company or Travere Therapeutics, Inc.: Who Invests More in Innovation?
Zoetis Inc. vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Bio-Techne Corporation and Travere Therapeutics, Inc. Trends
HUTCHMED (China) Limited and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown